[Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas].
D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007272:Injections, Intralymphatic; D007275:Injections, Intravenous; D007456:Iodine Isotopes / Q000627:therapeutic use*; D007945:Leukemia, Lymphoid / Q000628:therapy; D008223:Lymphoma / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use*; D008875:Middle Aged; D012186:Retroperitoneal Neoplasms / Q000628:therapy*; D014265:Triethylenemelamine / Q000627:therapeutic use*
D007456:Iodine Isotopes; D008466:Mechlorethamine; D003520:Cyclophosphamide; D014265:Triethylenemelamine
L'association de la radiothérapie endolymphatique de des agents alkylants dans le traitement des hématosarcomes rétropéritonéaux.